Nice

News

NICE backs "artificial pancreas" tech for type 1 diabetics

More than 100,000 people in England and Wales with type 1 diabetes that they find hard to control with current therapy could soon be offered new technology via the NHS.

News

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

The UK healthcare sector is mourning one of the most eminent of its figures in the last few decades – Professor Sir Mike Rawlins – who has passed away at the age of 81.

News

NICE expands breast cancer patient population eligible for E...

AstraZeneca and Daiichi Sankyo's Enhertu will become an option for hundreds more people with breast cancer in England and Wales, thanks to new guidance from NICE that will make it available

Patients

What does the future of European healthcare look like?

After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term?

News

NICE backs use of Boehringer's Ofev in IPF from diagnosis

Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim's Ofev, following new guidance from health technology assess

News

MHRA, NHS England make available new prostate cancer treatme...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT) in combination with docetaxel is to be the first prostate cancer treatment to be mad

NICE backs "artificial pancreas" tech for type 1 diabetics

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

NICE expands breast cancer patient population eligible for E...

What does the future of European healthcare look like?

NICE backs use of Boehringer's Ofev in IPF from diagnosis

MHRA, NHS England make available new prostate cancer treatme...

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

Nice

Editor's Picks